Broussonetia papyrifera (L.) Vent. and Lonicera japonica Thunb. have been used in recent medicinal research for their antioxidative and anti-inflammatory properties. The present study investigated the therapeutic efficacy of B. papyrifera and L. japonica ethanolic extracts in a murine model of ovalbumin-induced asthma, in which intra-peritoneal (IP) injections and aerosol ovalbumin delivery were used to induce allergic asthma. Bronchioalveolar lavage fluid (BALF), serum samples, lungs and livers were collected from the experimental groups. In the groups treated with B. papyrifera and L. japonica extracts, CD3, CD4, serum IgE and IL-4 levels; activities of matrix metalloproteinase (MMP)-2 and MMP-9; and eotaxin levels in the BALF significantly decreased to near normal levels. Results of a histopathological analysis showed that the level of inflammation and mucous secretions reduced in the treated groups compared to the corresponding levels in the other groups. Moreover, results of a serum enzymatic analysis showed the non-toxic nature of the extracts in the B. papyrifera and L. japonica treated groups. Taken together, these results clearly indicate that the B. papyrifera and L. japonica extracts may be very effective against asthma and inflammation related diseases.
The prevalence of asthma is increasing [1, 2] . Asthma is an allergic respiratory disease characterized by airway obstruction, bronchial hyper-responsiveness, mucus over-production and eosinophilic infiltration. Activation of T cells, especially T helper 2 (Th2)-type T cells, drives asthmatic allergic responses, including production of allergic cytokines and T lymphocyte recruitment to the lung [3] .
Interleukin-4 (IL-4) is a cytokine critical to the differentiation of Th2-type T cells from naïve T lymphocytes (Th0) [4] . These Th2type T cells produce IL-4, IL-5, IL-9 and IL-13 [5] . Enhanced release of Th2 cytokines triggers an increase in IgE levels, mucus secretion, eosinophilia and T cell activation [6] . Some of these effects are mediated by IL-4, which induces isotype switching of B lymphocytes to IgE-producing cells [7] and inhibits apoptosis of eosinophils and induces eosinophil activation by increasing eotaxin expression [8] . In patients showing atopy, Th2 as well as CD4+ T cells produce IL-4 and IL-5 [6] . In fact, persistent asthma is correlated with inflammation and deposition of extracellular matrix proteins and it may mediate release of matrix metalloproteinases (MMPs) [9] . MMPs are strongly expressed at sites of inflammation, and both MMP-2 and MMP-9 are predominantly secreted by T cells [10] .
Many medications have been used in asthma treatment, including beta2-agonists and inhaled corticosteroids, but these have limitations and cause side effects in patients. Interestingly, leukotriene antagonists and corticosteroids are commonly used in the treatment of asthma. However, they have too many side effects, including severe adrenal suppression. Recently, the trend worldwide has been to use phytochemical therapeutics, because they are both economical and largely free from adverse effects.
B. papyrifera (L.) Vent. belongs to Moraceae family. Papyriflavonol A (PapA), isolated from the root bark of B. papyrifera (L.) Vent. shows activity against pathogenic bacteria and fungi [11] . It also prevents passive cutaneous anaphylaxis [12] . Lonicera japonica Thunb. belongs to Caprifoliace family and is also called Japanese honeysuckle or Jin Yin Hua. L. japonica also has anti-inflammatory and analgesic activities [13] . The combination of B. papyrifera and L. japonica total fractions exhibits strong antiinflammatory effects [14] . Therefore, we selected these two bioactive extracts for this study, the major objective of which was to determine the efficacy of the combination of B. papyrifera and L. japonica as an anti-asthma agent.
To relieve the symptoms of asthma, beta2-agonists, such as salbutamol, albuterol and long-acting beta2-agonists (LABA), are NPC Natural Product Communications 2013 Vol. 8 No. 11 1609 -1614 used as the first-line therapy [15] . Omalizumab, a humanized monoclonal anti-IgE antibody, is used to treat severe allergic asthma [16] , and can reduce asthma exacerbations due to inhaled corticosteroid therapy [17] . However, these medications have limitations and cause side effects in patients. Local side effects of inhaled corticosteroids include oral candidiasis, hoarseness and dysphonia, along with systemic side effects including easy bruising, reduction in growth velocity and reduced bone mineral density [18] , and adrenal suppression [19] . Albuterol is a short-acting beta2 agonist that causes hyperlactic acidosis [20] . Cardiovascular side effects or even sudden death can result from asthmatic hypoxia combined with use of beta2 agonists [21] . In recent research, some extracts of natural product showed either anti-inflammatory or antioxidative stress potency [22, 23] . For these reasons, in this study, we focused on natural products that might have fewer side effects. In a previous study, a total B. papyrifera flavonoid fraction, in combination with L. japonica fraction, showed anti-inflammatory activity [14] . In this study, we studied the therapeutic effects of these herbal extracts on allergic asthma. Among 7 experimental groups, the montelukast (a leukotriene antagonist) group was set as a positive control because of its bronchodilatory and antiinflammatory effects [24] . In addition, montelukast treatment combined with that of an induced nitric oxide synthase (iNOS) inhibitor showed reduction in inflammation and oxidative stress [25] . First, we sensitized mice by intraperitoneal injection of ovalbumin (Days 0 and 14), and then administered ovalbumin inhalation for 3 days continuously (Days 21-23). On Days 18-23, extract of either B. papyrifera and L. japonica or montelukast were also administered to the mice ( Figure 1 ).
Increase in the number of cells in the BALF is a significant marker for inflammation, and also suggests asthma induction [26] . Therefore, we counted the total number of cells in BALF samples. In induced (i.e., ovalbumin-challenged and ovalbumin-inhaled) but untreated groups (Alum and Vehicle groups), total cell numbers were significantly increased. In contrast, total cell numbers in treated groups (groups treated with 100, 200, and 400 mg/kg of extract, and montelukast groups) significantly decreased compared to those in the induced but untreated groups (Alum and Vehicle groups) ( Figure 2 ). To determine the efficacy of B. papyrifera and L. japonica extracts in the asthma model, we used fluorescence-activated cell sorting (FACS), ELISA, and Western blot analyses to evaluate immune reactions as therapeutic markers, including cluster of differentiation (CD) proteins and cytokines. FACS revealed significantly decreased numbers of CD3 and CD4 lymphocytes in all of the treated groups (groups treated with 100, 200 and 400 mg/kg of extract, and montelukast groups) compared to those in the Alum and Vehicle groups ( Figure 3A, B ). CD3 and CD4 counts in the treated groups, especially in the 200 and 400 mg/kg groups, were either the same or lower than 50% of those in the untreated group numbers. When CD3 and CD4 lymphocytes were analyzed simultaneously, the proportion of activated lymphocytes in the treated groups also significantly decreased compared with those in the untreated groups ( Figure 3C ). A previous study showed significantly reduced activation of CD3 and CD4 T-lymphocytes in asthma patients treated with the test drug [27] . Therefore, our results suggest that the B. papyrifera and L. japonica extracts exhibit anti-inflammatory therapeutic effects related to T-lymphocyte immunity. inflammations such as asthma, IL-4 is a key cytokine because it induces B lymphocyte isotype switching to an immunoglobulin (Ig)-E secreting isotype [28] , increases the expression of eotaxin [29] , and activates mast cells and mucin hypersecretion [30] . Furthermore, IL-4 induces the differentiation of Th0 lymphocytes into Th2 lymphocytes [4] . Our results showed that IL-4 levels in BALF in most treatment groups significantly decreased compared to those in the Alum and Vehicle groups ( Figure 4A ). Compared to the untreated groups, the 400mg/kg and montelukast groups showed significantly decreased serum IgE levels ( Figure 4B ). These results indicate that asthma was alleviated, especially in the groups treated with 400 mg/kg extract. Furthermore, compared to the Vehicle group, the treated groups showed decreased eotaxin levels in BALF. The average eotaxin levels in the Alum group tended to be higher than all the treated groups; however, the differences were not statistically significant ( Figure 4C ). The groups treated with the combination of B. papyrifera and L. japonica extracts also showed lower levels of IL-4, eotaxin, and IgE in BALF or serum than the corresponding levels shown by the Alum and Vehicle groups. Taken together, these data indicate that allergic symptoms related to Th2-type T lymphocytes and cytokines were significantly ameliorated in the groups treated with 400 mg/kg extract and montelukast. Inflammatory cytokines such as IL-4 stimulate the secretion of MMPs in asthma status [31] , thereby leading to high levels of expression at inflamed sites. In particulat, MMP-2 levels increase in cases of inflammatory injuries [32] ; further, in sputum samples of asthma patients, higher gelatinolytic activities related to MMP-2 and MMP-9 were noted [33] . In this study, Western blots were performed to determine the expression levels of MMP-9 in homogenized lung tissue samples. MMP-9 levels in the groups treated with 200 and 400 mg/kg extract significantly decreased compared to the levels in the Vehicle group and the group treated with 100 mg/kg extract. Moreover, compared to the group treated with 200 mg/kg extract, the group treated with 400 mg/kg extract showed a significant decrease. MMP-9 protein expression was measured by densitometry of the bands-of-interest in the Western blots ( Figure 5 ). MMP-2 activity was also assessed by the zymography method. The groups treated with 200 and 400 mg/kg extract showed higher MMP-2 gelatinolytic activities ( Figure 5A ). Our data show lower secretion of MMP-2 and MMP-9 after treatment with the B. papyrifera and L. japonica extracts, most likely a result of the inhibition of IL-4 cytokine secretion and decrease in T lymphocyte activation described earlier.
To determine the therapeutic efficacy of the extracts in the lungs, we performed a histopathological examination using hematoxylin and eosin (H&E) and periodic acid-Schiff (PAS) staining. H&E staining revealed that inflammatory cells appearing to be neutrophils (among other types) infiltrated the lung tissues in the non-treated groups. In contrast, the extract-treated groups demonstrated less infiltration ( Figure 6A and B) . PAS staining revealed that mucus production significantly decreased in the extract treated groups. In the non-treated groups most of the epithelial cells were covered by mucus, an effect ameliorated in the extract-treated groups ( Figure 6C ). To examine the toxicity of the extract, the highest administered dose of 400 mg/kg extract was selected, and serum levels of alanine transaminse (ALT) and aspartate transaminase (AST) were quantified. In the extract treated groups, ALT and AST levels were not significantly changed compared to the corresponding levels in the treatment of Naïve group. Moreover, the test group showed ALT and AST levels similar to the corresponding levels in the montelukast group ( Figure 7A and B) . For these reasons, B. papyrifera and L. japonica extracts appear to be biocompatible treatments for asthma. In conclusion, in this study, we used the latest assays to elucidate the potential mechanisms through which B. papyrifera and L. japonica extracts exert their therapeutic effects. Our results suggest that the application of these extracts can be recommended because of their potent antioxidant, anti-inflammatory, and antiasthmatic activities; very low toxicity; and cost effectiveness. This work has added importance since there is a recent worldwide trend of the use of natural therapeutics.
Experimental

Materials:
Ovalbumin was purchased from Pierce (Rockford, IL) and alum from Thermo Scientific (Bremen, Germany). Dimethyl sulfoxide (Sigma, St Louis, MO) was used to prepare the extract of Bp and Lj. Zoletil® (tiletamine hydrochloride and zolazepam hydrochloride) was purchased from Virbac (Carros, France). Miliplex mouse cytokine panel I -5 plex kit (Millipore, USA) was used to detect IL-4 and Eotaxin, IgE ELISA kit was purchased from USCN Life Science Incorporation (China). FITC-conjugated antimurine CD3 and PE-conjugated anti-murine CD4 antibodies were purchased from BD biosciences (San Jose, CA), MMP-9 antibody from Abcam (Cambridge, UK) and actin antibody from SantaCruz (CA, USA).
Preparation of Broussonetia papyrifera and Lonicera japonica extract:
Broussonetia papyrifera (Bp) dried root bark was extracted with 100% ethanol according to the ethanol thermal extraction method. The extract was dried under vacuum and then dissolved in water. After fractionation with ethyl acetate, the fraction was subsequently dried and used in the experiment. The yield of Bp dried fraction was approximately 4.2%, w/w. Papyriflavonol A and broussochalcone A were found in this fraction with contents of 0.33% and 1.03%, respectively, according to HPLC analysis. Dried Lonicera japonica (Lj) was extracted with 70% ethanol at room temperature. The extract was dried under vacuum and used in the experiment. The final yield of Lj was approximately 9.7%, w/w. Loganin and swerosid, analyzed by HPLC, formed 4.19% and 3.30%, respectively. The detailed content, characterization and information of extracts have been described in the works of Jin and colleagues [14] .
Animals and induction of mouse asthma model:
Six-week-old female BALB/c mice were purchased from Joongang Laboratory Animal Inc. (Seoul, Korea) and maintained in the laboratory animal facility with temperature and relative humidity maintained at 23±2°C and 50±20%, respectively, and a 12 h light/dark cycle. Mice were randomly divided into 7 groups (n=7); summarized in Table 1 . A mouse asthma model was induced [34] . Intra-peritoneal (IP) injections of ovalbumin (20 µg per mouse) with alum (2 mg / mouse) in normal saline, total volume 0.2 ml, were made twice (days 0, 14) to sensitize the mice to allergen. Ovalbumin (1% wt/mL ovalbumin in 0.9% normal saline inhalation for 30 min) was delivered for 3 days continuously (day 21, 22, and 23). At the same time, extract of Bp and Lj was orally administered for 6 days continuously (day 18, 19, 20, 21, 22 and 23) . Extracts of Bp and Lj 100, 200 and 400 mg/kg administered groups were orally administered in a dose-dependent manner. Montelukast was orally administered at 10 mg/kg to the appropriate group. The naïve group was challenged with normal saline. After repeated inhalations and treatments, 48 h later (day 25), mice were sacrificed and BALF, serum, lungs and livers were collected (Figure 1 ). All methods used in this study were approved by the Animal Care and Use Committee at Seoul National University (SNU-100222-1).
Collection of bronchioalveolar lavage fluid (BALF):
Mice were sacrificed using an overdose (500 μL) of Zoletil ® (tiletamine hydrochloride and zolazepam hydrochloride, Virbac, France) / xylazine. After tracheotomy, 0.5 mL of PBS was instilled into the lungs and the first supernatant of BALF (400 × g, 10 min) was collected for the measurement of cytokine and stored at -70°C. Further BALF was collected an additional 4 times by aspiration; a total of approximately 4 mL was collected and centrifuged. All cell pellets were collected and re-suspended in red blood cell (RBC) lysis buffer for 5 min. After RBC lysis, cells were washed 3 times and re-suspended in PBS. Total cell numbers were counted using a hemocytometer for the relationship between increased cell numbers in BALF and inflammation.
Measurement of IL-4 in BALF and IgE, eotaxin in serum:
Levels of IL-4 in BALF, and IgE and eotaxin in serum were measured using an enzyme-linked immunosorbent assay (ELISA) kit, according to the manufacturer's instructions.
Zymography: MMP-2 activity was assessed by a gelatin zymography method. Lung tissues were homogenized in Passive Lysis Buffer ® (Promega) and centrifuged (13200 g, 4°C, 30 min). Fifty µg of protein were loaded for gelatin zymography. Gels were composed of 10% SDS-PAGE containing 1% gelatin. After electrophoresis (80V), gels were washed twice in 2.5% Triton X-100 for 30 min and then incubated in collagenase buffer (1M Tris-HCl pH 7.6, NaCl, CaCl 2 and Brij-35) for 24 h. After incubation, gels were stained with Coomassie brilliant blue reagent and destained with 10% methanol and 10% acetic acid solution. Gelatinase activities were assessed by observing white bands on gels.
Flow cytometry: BAL fluid cells were re-suspended in PBS and stained with FITC-conjugated anti-murine CD3 mAb and PEconjugated anti-murine CD4 mAb in a separate reaction. Cells were washed with PBS and fixed in 4% paraformaldehyde overnight. Flow cytometry was performed using a FACS Calibur analytical flow cytometer (BD biosciences) and 1×10 4 cells were used for analysis.
Western blot analysis:
Fifty µg of lung homogenate protein was analyzed on SDS-PAGE. Proteins were separated and transferred to nitrocellulose membranes and blocked for 1 h in 5% skim milk. The nitrocellulose membranes were incubated overnight with corresponding primary antibodies in 5% skim milk at 4°C. After that, the membranes were incubated with horse radish peroxidase conjugating secondary antibodies (Invitrogen) for either 3 h at room temperature or overnight at 4°C. After washing with TTBS (Tris-Buffered Saline + Tween 20) solution for 30 min, bands were detected using a luminescent image analyzer LAS-3000 (Fujifilm, Tokyo, Japan). Quantification of Western blot bands was performed by Multi Gauge version 2.02 software (Fujifilm, Tokyo, Japan).
Tissue histopathology:
Lung tissues not used for BALF collections were fixed in 10% formalin and embedded in paraffin, sectioned at 3 um thickness, and stained with hematoxylin (Sigma GHS-116), eosin (Sigma HT-110116) for H&E staining and periodic acid-Schiff (PAS) (Sigma 395B) to detect mucus production. Tissues were mounted and cover slipped using Dako mounting medium (Dakocytomation, Denmark, CA).
Detection of ALT and AST levels in serum:
Alanine transaminase (ALT) and aspartate transaminase (AST) levels in serum were analyzed by a ChemaDiagnostica automatic analyzer (Olympus, JP/AU400) according to the manufacturer's instructions for the examination of liver toxicity.
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